课题基金 / 基金详情

Role of miR-574 driver and passenger strands in cardiac hypertrophy

Role of miR-574 driver and passenger strands in cardiac hypertrophy
miR-574驱动链和过客链在心脏肥大中的作用
批准号:
9336417
负责人:
Peng Yao
金额:
$38.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-19 至 2018-08-31

项目摘要

项目成果

Peng Yao的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结:
英文摘要
Project Summary: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Better understanding of the pathological mechanisms underlying CVD will improve preventive and therapeutic interventions. One major etiology of CVD is dysregulation of cardiac gene expression by transcription factors (TFs) and microRNAs (miRNAs). miRNAs are small non-coding RNAs involved in gene expression regulation. TFs are usually poor small-molecule drug targets. However, miRNAs can act as unique therapeutic agents because they can target multiple TFs in the same pathological pathway. Most precursor miRNAs (pre-miRNAs) are processed to generate an active driver strand miRNA; the complementary passenger strand is usually degraded. Intriguingly, pre-miR-574 produces two functional strands—miR-574-5p and miR-574-3p. We found that both strands of miR-574 play a synergistic role to protect hearts from cardiac hypertrophy. We showed that miR-574-5p was induced in chronic human heart failure tissues versus normal hearts. We found that miR-574-5p is up-regulated under hypertrophic and ischemic stress and silences the expression of three pro-hypertrophy TFs myocyte enhancer factor–2 factors (Mef2a/2c/2d) and prevents cardiomyocyte (CM) hypertrophy. Transfection of miR-574-5p mimics in mouse cardiomyocytes (CM) protects the cells from isoproterenol (ISO, a β-adrenergic agonist)-induced hypertrophy and hypoxia-serum starvation-induced cell death. miR-574 knockout mice exhibit an advanced cardiac hypertrophy phenotype associated with increased fibrosis and enlarged CM, compared to wild-type mice after chronic ISO injection. We also showed that the passenger strand miR-574-3p is co-upregulated with miR-574-5p but captured by hypoxia-activated phospho-hnRNP L (heterogeneous nuclear ribonucleoprotein L). miR-574-3p is secreted from CM via exosomes and targets fibroblasts to reduce fibrosis. Our research goal is to address fundamental questions in miRNA biology using miR-574-5p/3p as archetypal molecules in the cardiac system (differential regulation, mechanistic diversity, and functional relationship between driver and passenger strands), and to treat HF by developing miRNA-based therapeutics that target TFs. Our central hypothesis is: In CM under hypertrophic and ischemic stress, differential regulation of the driver strand miR-574-5p and passenger strand miR-574-3p integrate cardiac gene expression and modulate pathological cardiac hypertrophy and remodelling. We will test this hypothesis by pursuing two aims. Aim 1 will test the hypothesis that miR-574-5p regulates the expression of Mef2 TFs and other cardiac genes via miRISC, thereby modulates cardiac hypertrophy and remodelling. Aim 2 will test the hypothesis that in CM ischemia promotes miR-574 transcription via specific TFs and activates capture of miR-574-3p by P-hnRNP L followed by exosome secretion and intercellular communication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
uORF-mediated Translational Control of Cardiac Transcription Factor Expression
  • 批准号:
    10659430
  • 项目类别:
  • 资助金额:
    $50.76万
  • 财政年份:
    2023
  • 负责人:
    Peng Yao
  • 依托单位:
Deciphering the role of FAM210A in cardiac physiopathology
  • 批准号:
    10717728
  • 项目类别:
  • 资助金额:
    $48.57万
  • 财政年份:
    2023
  • 负责人:
    Peng Yao
  • 依托单位:
Translational Control of Cardiac Fibrosis
  • 批准号:
    10470324
  • 项目类别:
  • 资助金额:
    $38.5万
  • 财政年份:
    2019
  • 负责人:
    Peng Yao
  • 依托单位:
Translational Control of Cardiac Fibrosis
  • 批准号:
    10220123
  • 项目类别:
  • 资助金额:
    $38.5万
  • 财政年份:
    2019
  • 负责人:
    Peng Yao
  • 依托单位:
海外基金